American International Group’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,905
| Closed | -$61K | – | 3232 |
|
|
2022
Q1 | $61K | Sell |
9,905
-697
| -7% | -$4.29K | ﹤0.01% | 2781 |
|
|
2021
Q4 | $134K | Sell |
10,602
-317
| -3% | -$4.01K | ﹤0.01% | 2592 |
|
|
2021
Q3 | $1M | Sell |
10,919
-259
| -2% | -$23.7K | 0.01% | 1447 |
|
|
2021
Q2 | $592 | Buy |
11,178
+2,011
| +22% | +$107 | ﹤0.01% | 1813 |
|
|
2021
Q1 | $330 | Buy |
9,167
+24
| +0.3% | +$1 | ﹤0.01% | 2075 |
|
|
2020
Q4 | $254 | Sell |
9,143
-263
| -3% | -$7 | ﹤0.01% | 2153 |
|
|
2020
Q3 | $470K | Sell |
9,406
-214
| -2% | -$10.7K | ﹤0.01% | 1620 |
|
|
2020
Q2 | $445K | Buy |
9,620
+2,883
| +43% | +$133K | ﹤0.01% | 1659 |
|
|
2020
Q1 | $307K | Sell |
6,737
-389
| -5% | -$17.7K | ﹤0.01% | 1671 |
|
|
2019
Q4 | $400K | Buy |
7,126
+5,243
| +278% | +$294K | ﹤0.01% | 1823 |
|
|
2019
Q3 | $47K | Buy |
1,883
+46
| +3% | +$1.15K | ﹤0.01% | 2899 |
|
|
2019
Q2 | $78K | Buy |
+1,837
| New | +$78K | ﹤0.01% | 2802 |
|